Device / Technology News

RSS

Orexo and SVF Vaccines collaborate to explore AmorphOX® formulation of LNP-mRNA vaccines

Orexo AB and SVF Vaccines AB today announced a research collaboration to investigate whether Orexo’s proprietary powder-based drug delivery technology, AmorphOX®, can be used to develop stable powder-based formulations of lipid nanoparticle (LNP)-encapsulated messenger RNA (mRNA) vaccines.

12 Nov 2026

Beyond food: Bran-based gels show potential for targeted drug delivery

When it comes to colon health, the benefits of wheat and rye bran in wholegrain foods are well-known. Now researchers in Sweden have shown how these fibers may have a therapeutic use, too.

12 Nov 2026

New method reveals how individual glioblastoma cells spread through the brain

By combining live imaging of brain tissue with artificial intelligence, researchers at Uppsala University have developed a method that reveals how individual glioblastoma cells spread through the brain, how they can switch between different ways of moving, and how they are affected by cancer treatments. An

12 Nov 2026

Drug ads can subtly sway AI medical treatment recommendations

As people increasingly turn to artificial intelligence (AI) for health information, a new study by researchers at the Icahn School of Medicine at Mount Sinai raises questions about what happens when commercial advertising appears alongside a clinical question.

11 Nov 2026

Thalamic responsive neurostimulation reduces seizures by over 80% in pediatric patients

Over the past two years, a Children's Hospital Los Angeles team has treated 10 children with thalamic responsive neurostimulation (RNS), a groundbreaking therapy for generalized epilepsy as well as Lennox Gastaut syndrome.

11 Nov 2026

Study evaluates AI tools for making medical documents easier to read

A team of researchers from the Universidad Carlos III de Madrid (UC3M) has evaluated various artificial intelligence (AI) language models to simplify medical reports and adapt them into clearer language for non-expert audiences.

11 Nov 2026

Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapy

Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will present preclinical proof-of-concept data at FLORetina-ICOOR 2026.

From Mogrify 11 Nov 2026

L.B. Bohle will be showcasing productive, energy-efficient and scalable OSD solutions at PMEC India 2026

The challenge for India’s pharmaceutical manufacturers is clear: How to reliably scale production, reduce energy costs, and safeguard operators – all at once. From November 24 to 26, 2026, L.B. Bohle will present these solutions at stand 9C02 in the India Expo Centre & Mart (IEML) in Greater Noida.

From L.B. Bohle Maschinen und Verfahren GmbH 11 Nov 2026

Job-search app boosts employment rates and reduces depressive symptoms

Losing a job can be a life-shattering experience. And when depression complicates a job search, unemployment can become a vicious cycle.

10 Nov 2026

Clinical trial evaluates fully implantable cochlear implant technology

University Hospitals is bringing the next generation of hearing technology to patients in Northeast Ohio as the only site in the state participating in a Phase 3 clinical trial evaluating the Totally Implantable Cochlear Implant (TICI).

10 Nov 2026

Lab Thread launches new AI tools and strengthens platform with universal AI assistant compatibility

Lab Thread Ltd, a UK-based life science software company, today announced the launch of a new Model Context Protocol (MCP) server that lets scientists connect their own AI assistants directly to their laboratory data.

From Lab Thread 10 Nov 2026

Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

Crystal Pharmatech, a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small-molecule drugs, today announced that installation of the ELDICO ED-1 electron diffractometer at its Suzhou, China R&D center is complete.

From ELDICO Scientific AG 10 Nov 2026

Five AI models tackled 227 pharmacy exam questions. Here's where they struggled

Researchers evaluated five large language models using 227 infectious disease-related pharmacy examination questions and found that all achieved approximately 90% accuracy, with ChatGPT-4o-mini scoring highest at 91.2%. Accuracy was significantly lower for medicinal chemistry, clinical microbiology, higher-order cognitive questions, and image-containing questions, raising concerns about relying on AI-generated answers without independent verification.

9 Nov 2026

VA grant funds implantable stimulator to improve the lives of disabled veterans

With a $3.1 million grant from the U.S. Department of Veterans Affairs (VA), a Case Western Reserve University (CWRU) researcher's quest to transform the quality of life of people living with spinal cord injuries will move closer to a clinical trial.

9 Nov 2026

AI tool uses emergency room narratives to predict PTSD risk

An AI tool can analyze patients' narratives about injuries that sent them to the emergency room to predict who will later develop post-traumatic stress disorder (PTSD), a new study found.

9 Nov 2026

Cleaner bedroom air linked to improved blood sugar control

Using portable filters to reduce exposure to air pollution during sleep may stabilize the large spikes in blood sugar experienced by people with prediabetes, a condition in which sugar (glucose) levels are higher than normal, a new study shows.

8 Nov 2026

MD Anderson and P-Cure join hands to advance proton and helium ion therapy

The University of Texas MD Anderson Cancer Center and P-Cure Ltd. today announced a strategic alliance to advance the development and clinical validation of a next-generation particle therapy platform designed to deliver both proton and helium ion therapy from a single compact upright treatment system.

8 Nov 2026

Searching for medicine in Europe? Not every Google result is what it seems

A study examining 9,000 Google search results across 30 European countries found that 36.3% of links to online medicine sellers led to illegal vendors, rising to nearly 77% for controlled substances. Countries that permitted legitimate online medicine sales generally had fewer illegal vendors among highly ranked search results than countries that prohibited such sales, although the observational findings do not establish causation.

8 Nov 2026

Portable testing method detects RNA viruses without laboratory equipment

A new protocol detects RNA viruses such as Zika and hepatitis C without traditional medical laboratory equipment.

6 Nov 2026

AI tool uncovers hidden interactions among human mitochondrial proteins

Artificial intelligence is helping Texas A&M AgriLife Research scientists fast-track answers to a long-standing question in human biology: What do hundreds of mystery proteins in the mitochondria actually do?

6 Nov 2026